DNLI
Price
$21.52
Change
-$0.26 (-1.19%)
Updated
Feb 4, 04:03 PM (EDT)
Capitalization
3.4B
26 days until earnings call
Intraday BUY SELL Signals
GLSI
Price
$26.83
Change
-$1.19 (-4.25%)
Updated
Feb 4, 02:47 PM (EDT)
Capitalization
388.27M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs GLSI

Header iconDNLI vs GLSI Comparison
Open Charts DNLI vs GLSIBanner chart's image
Denali Therapeutics
Price$21.52
Change-$0.26 (-1.19%)
Volume$563
Capitalization3.4B
Greenwich LifeSciences
Price$26.83
Change-$1.19 (-4.25%)
Volume$303
Capitalization388.27M
DNLI vs GLSI Comparison Chart in %
DNLI
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DNLI vs. GLSI commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DNLI: $21.78 vs. GLSI: $28.02)
Brand notoriety: DNLI and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 101% vs. GLSI: 61%
Market capitalization -- DNLI: $3.4B vs. GLSI: $388.27M
DNLI [@Biotechnology] is valued at $3.4B. GLSI’s [@Biotechnology] market capitalization is $388.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and GLSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than GLSI.

Price Growth

DNLI (@Biotechnology) experienced а +2.49% price change this week, while GLSI (@Biotechnology) price change was -16.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 02, 2026.

GLSI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.4B) has a higher market cap than GLSI($388M). GLSI (33.389) and DNLI (31.920) have similar YTD gains . GLSI has higher annual earnings (EBITDA): -19.58M vs. DNLI (-534.17M). DNLI has more cash in the bank: 848M vs. GLSI (3.81M). DNLI (0) and GLSI (0) have equivalent revenues.
DNLIGLSIDNLI / GLSI
Capitalization3.4B388M877%
EBITDA-534.17M-19.58M2,728%
Gain YTD31.92033.38996%
P/E RatioN/AN/A-
Revenue00-
Total Cash848M3.81M22,275%
Total Debt44.4MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIGLSI
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
83%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAPRX11.890.21
+1.80%
Cohen & Steers Real Assets R
FMIEX11.860.12
+1.02%
Wasatch Global Value Investor
FIQAX17.55N/A
N/A
Fidelity Advisor Asset Manager 60% Z
CCMMX9.23N/A
N/A
Conestoga Mid Cap Investors
NBMIX53.93-0.12
-0.22%
Neuberger Small Cap Growth Inv

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-12.34%
IMNM - GLSI
42%
Loosely correlated
+3.18%
IPSC - GLSI
38%
Loosely correlated
N/A
DNLI - GLSI
38%
Loosely correlated
-4.22%
CRBU - GLSI
37%
Loosely correlated
+6.85%
CELC - GLSI
37%
Loosely correlated
-0.31%
More